<DOC>
	<DOCNO>NCT00102193</DOCNO>
	<brief_summary>The purpose study demonstrate safety effectiveness Adacolumn Apheresis System treat sign symptom ulcerative colitis .</brief_summary>
	<brief_title>Study Treatment Ulcerative Colitis With Adacolumn</brief_title>
	<detailed_description>Trial Features : - Non-drug therapy - Most patient remain current treatment regimen , include prednisone , budesonide medication Asacol ( mesalamine ) , Pentasa ( mesalamine ) , Colazal ( balsalazide disodium ) Dipentum ( olsalazine sodium ) throughout study Components Study : - Study length 24 week , include screen visit , ten treatment visit nine week 4 follow-up appointment - Physical exam , laboratory test disease assessment conduct charge patient - 2:1 Randomization ( treatment : sham )</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Key Moderate severe active ulcerative colitis colonic involvement ulcerative colitis beyond 15 cm anal verge Adequate peripheral venous access allow completion apheresis treatment Receiving one follow medical therapy : *sulfasalazine , *mesalamine 5ASA agent , *prednisone 6mercaptopurine azathioprine OR Have receive medical therapy due intolerance demonstrate nonresponse Agree participate require followup visit Able complete diary Signed write informed consent document authorization use protect health information Key Evidence toxic megacolon Major surgery within past 6 week anticipate need surgery within 12 week Proctocolectomy , total colectomy , ileostomy , stoma ileal pouchanal anastomosis Requiring inpatient hospitalization A history allergic reaction heparin heparininduced thrombocytopenia A history hypersensitivity reaction associate apheresis procedure intolerance apheresis procedures A history severe cardiovascular peripheral arterial diseases A history cerebral vascular disease Liver diseases Renal insufficiency Insulindependent Type I Type II diabetes Known bleed disorder use concomitant anticoagulant therapy purpose apheresis treatment Any hypercoagulable disorder Known infection Hepatitis B C , HIV Severe anemia Leukopenia granulocytopenia Evidence current systemic infection Malignancy Pregnant , lactate plan become pregnant course investigational study Used within last 30 day , investigational drug , biologic device 5 halflives , know , investigational drug biologic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Ulcerative Colitis , Apheresis</keyword>
</DOC>